ExsoMed receives FDA 510(k) clearance for cannulated lag screw system
Click Here to Manage Email Alerts
ExsoMed Corporation has announced FDA 510(k) clearance of the NanoPhix cannulated lag screw system for use in common fragment fracture surgeries, such as for avulsion, mallet and condylar fractures, according to a press release.
“Surgeons have shared with us their desire for a lag screw system that actually works,” James Young Kim, chief marketing officer of ExsoMed, said in the release. “Current solutions in the marketplace have fallen short of surgeon demands, specifically from a surgical technique and ease of use perspective. NanoPhix and ExsoMed’s innovative dual guidewire delivery mechanism will enable hand surgeons to further address those issues encountered during cases and help improve surgical efficiencies and most importantly, patient outcomes.”
The NanoPhix cannulated lag screw system will be launched in the fourth quarter of 2022, according to the release.
Read more about
Click Here to Manage Email Alerts